 | • レポートコード：20QY06-00906 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、インフルエンザ薬＆ワクチンのグローバル市場について種類別（ザナミビル、リン酸オセルタミビル、ペラミビル、3価、4価）、用途別（病院、研究所、薬局、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・インフルエンザ薬＆ワクチン市場の概要 ・世界の主要地域別インフルエンザ薬＆ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のインフルエンザ薬＆ワクチン市場規模2015-2026：種類別（ザナミビル、リン酸オセルタミビル、ペラミビル、3価、4価） ・世界のインフルエンザ薬＆ワクチン市場規模2015-2026：用途別（病院、研究所、薬局、その他） ・インフルエンザ薬＆ワクチンの北米市場規模2015-2020 ・インフルエンザ薬＆ワクチンのヨーロッパ市場規模2015-2020 ・インフルエンザ薬＆ワクチンの中国市場規模2015-2020 ・インフルエンザ薬＆ワクチンの日本市場規模2015-2020 ・インフルエンザ薬＆ワクチンの東南アジア市場規模2015-2020 ・インフルエンザ薬＆ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （GlaxoSmithKline、Sanofi Pasteur、CSL Limited、Astrazeneca、Protein Sciences Corporation、Serum Institute Of India Pvt. Ltd.、Emergent Biosolutions、Emergent Biosolutions、BioCryst Pharmaceuticals.Inc.、Alvogen、ABPI） ・インフルエンザ薬＆ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・インフルエンザ薬＆ワクチンの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Influenza Drugs and Vaccines Market
The global Influenza Drugs and Vaccines market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Influenza Drugs and Vaccines Scope and Market Size
The global Influenza Drugs and Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Drugs and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Influenza Drugs and Vaccines market is segmented into
Zanamivir
Oseltamivir Phosphate
Peramivir
Trivalent
Quadrivalent
Segment by Application, the Influenza Drugs and Vaccines market is segmented into
Hospitals
Research Laboratories
Pharmacies
Others
The Influenza Drugs and Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the Influenza Drugs and Vaccines market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Influenza Drugs and Vaccines Market Share Analysis
Influenza Drugs and Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Influenza Drugs and Vaccines business, the date to enter into the Influenza Drugs and Vaccines market, Influenza Drugs and Vaccines product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline
Sanofi Pasteur
CSL Limited
Astrazeneca
Protein Sciences Corporation
Serum Institute Of India Pvt. Ltd.
Emergent Biosolutions
Emergent Biosolutions
BioCryst Pharmaceuticals.Inc.
Alvogen
ABPI
Table of Contents
1 Influenza Drugs and Vaccines Market Overview
1.1 Influenza Drugs and Vaccines Product Scope
1.2 Influenza Drugs and Vaccines Segment by Type
1.2.1 Global Influenza Drugs and Vaccines Sales by Type (2020-2026)
1.2.2 Zanamivir
1.2.3 Oseltamivir Phosphate
1.2.4 Peramivir
1.2.5 Trivalent
1.2.6 Quadrivalent
1.3 Influenza Drugs and Vaccines Segment by Application
1.3.1 Global Influenza Drugs and Vaccines Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Research Laboratories
1.3.4 Pharmacies
1.3.5 Others
1.4 Influenza Drugs and Vaccines Market Estimates and Forecasts (2015-2026)
1.4.1 Global Influenza Drugs and Vaccines Sales Growth Rate (2015-2026)
1.4.2 Global Influenza Drugs and Vaccines Revenue and Growth Rate (2015-2026)
1.4.3 Global Influenza Drugs and Vaccines Price Trends (2015-2026)
2 Influenza Drugs and Vaccines Estimate and Forecast by Region
2.1 Global Influenza Drugs and Vaccines Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Influenza Drugs and Vaccines Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Influenza Drugs and Vaccines Sales Market Share by Region (2015-2020)
2.2.2 Global Influenza Drugs and Vaccines Revenue Market Share by Region (2015-2020)
2.3 Global Influenza Drugs and Vaccines Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Influenza Drugs and Vaccines Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Influenza Drugs and Vaccines Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Influenza Drugs and Vaccines Estimates and Projections (2015-2026)
2.4.2 Europe Influenza Drugs and Vaccines Estimates and Projections (2015-2026)
2.4.3 China Influenza Drugs and Vaccines Estimates and Projections (2015-2026)
2.4.4 Japan Influenza Drugs and Vaccines Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Influenza Drugs and Vaccines Estimates and Projections (2015-2026)
2.4.6 India Influenza Drugs and Vaccines Estimates and Projections (2015-2026)
3 Global Influenza Drugs and Vaccines Competition Landscape by Players
3.1 Global Top Influenza Drugs and Vaccines Players by Sales (2015-2020)
3.2 Global Top Influenza Drugs and Vaccines Players by Revenue (2015-2020)
3.3 Global Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Drugs and Vaccines as of 2019)
3.4 Global Influenza Drugs and Vaccines Average Price by Company (2015-2020)
3.5 Manufacturers Influenza Drugs and Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Influenza Drugs and Vaccines Players (Opinion Leaders)
4 Global Influenza Drugs and Vaccines Market Size by Type
4.1 Global Influenza Drugs and Vaccines Historic Market Review by Type (2015-2020)
4.1.1 Global Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
4.1.2 Global Influenza Drugs and Vaccines Revenue Market Share by Type (2015-2020)
4.1.3 Global Influenza Drugs and Vaccines Price by Type (2014-2020)
4.2 Global Influenza Drugs and Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Influenza Drugs and Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Influenza Drugs and Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Global Influenza Drugs and Vaccines Price Forecast by Type (2021-2026)
5 Global Influenza Drugs and Vaccines Market Size by Application
5.1 Global Influenza Drugs and Vaccines Historic Market Review by Application (2015-2020)
5.1.1 Global Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
5.1.2 Global Influenza Drugs and Vaccines Revenue Market Share by Application (2015-2020)
5.1.3 Global Influenza Drugs and Vaccines Price by Application (2015-2020)
5.2 Global Influenza Drugs and Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Influenza Drugs and Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Influenza Drugs and Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Influenza Drugs and Vaccines Price Forecast by Application (2021-2026)
3 North America Influenza Drugs and Vaccines Market Facts & Figures
3.2 North America Influenza Drugs and Vaccines Sales Market Share by Company (2015-2020)
3.3 North America Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
3.4 North America Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
4 Europe Influenza Drugs and Vaccines Market Facts & Figures
4.2 Europe Influenza Drugs and Vaccines Sales Market Share by Company (2015-2020)
4.3 Europe Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
4.4 Europe Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
5 China Influenza Drugs and Vaccines Market Facts & Figures
5.2 China Influenza Drugs and Vaccines Sales Market Share by Company (2015-2020)
5.3 China Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
5.4 China Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
6 Japan Influenza Drugs and Vaccines Market Facts & Figures
6.2 Japan Influenza Drugs and Vaccines Sales Market Share by Company (2015-2020)
6.3 Japan Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
6.4 Japan Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
7 Southeast Asia Influenza Drugs and Vaccines Market Facts & Figures
7.2 Southeast Asia Influenza Drugs and Vaccines Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
8 India Influenza Drugs and Vaccines Market Facts & Figures
8.2 India Influenza Drugs and Vaccines Sales Market Share by Company (2015-2020)
8.3 India Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
8.4 India Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Influenza Drugs and Vaccines Business
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Influenza Drugs and Vaccines Corporation Information
12.1.2 GlaxoSmithKline Influenza Drugs and Vaccines Business Overview and Total Revenue
12.1.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GlaxoSmithKline Influenza Drugs and Vaccines Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 Sanofi Pasteur
12.2.1 Sanofi Pasteur Influenza Drugs and Vaccines Corporation Information
12.2.2 Sanofi Pasteur Influenza Drugs and Vaccines Business Overview and Total Revenue
12.2.3 Sanofi Pasteur Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Sanofi Pasteur Influenza Drugs and Vaccines Products Offered
12.2.5 Sanofi Pasteur Recent Development
12.3 CSL Limited
12.3.1 CSL Limited Influenza Drugs and Vaccines Corporation Information
12.3.2 CSL Limited Influenza Drugs and Vaccines Business Overview and Total Revenue
12.3.3 CSL Limited Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.3.4 CSL Limited Influenza Drugs and Vaccines Products Offered
12.3.5 CSL Limited Recent Development
12.4 Astrazeneca
12.4.1 Astrazeneca Influenza Drugs and Vaccines Corporation Information
12.4.2 Astrazeneca Influenza Drugs and Vaccines Business Overview and Total Revenue
12.4.3 Astrazeneca Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Astrazeneca Influenza Drugs and Vaccines Products Offered
12.4.5 Astrazeneca Recent Development
12.5 Protein Sciences Corporation
12.5.1 Protein Sciences Corporation Influenza Drugs and Vaccines Corporation Information
12.5.2 Protein Sciences Corporation Influenza Drugs and Vaccines Business Overview and Total Revenue
12.5.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Protein Sciences Corporation Influenza Drugs and Vaccines Products Offered
12.5.5 Protein Sciences Corporation Recent Development
12.6 Serum Institute Of India Pvt. Ltd.
12.6.1 Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Corporation Information
12.6.2 Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Business Overview and Total Revenue
12.6.3 Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Products Offered
12.6.5 Serum Institute Of India Pvt. Ltd. Recent Development
12.7 Emergent Biosolutions
12.7.1 Emergent Biosolutions Influenza Drugs and Vaccines Corporation Information
12.7.2 Emergent Biosolutions Influenza Drugs and Vaccines Business Overview and Total Revenue
12.7.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Emergent Biosolutions Influenza Drugs and Vaccines Products Offered
12.7.5 Emergent Biosolutions Recent Development
12.8 Emergent Biosolutions
12.8.1 Emergent Biosolutions Influenza Drugs and Vaccines Corporation Information
12.8.2 Emergent Biosolutions Influenza Drugs and Vaccines Business Overview and Total Revenue
12.8.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Emergent Biosolutions Influenza Drugs and Vaccines Products Offered
12.8.5 Emergent Biosolutions Recent Development
12.9 BioCryst Pharmaceuticals.Inc.
12.9.1 BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Corporation Information
12.9.2 BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Business Overview and Total Revenue
12.9.3 BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.9.4 BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Products Offered
12.9.5 BioCryst Pharmaceuticals.Inc. Recent Development
12.10 Alvogen
12.10.1 Alvogen Influenza Drugs and Vaccines Corporation Information
12.10.2 Alvogen Influenza Drugs and Vaccines Business Overview and Total Revenue
12.10.3 Alvogen Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Alvogen Influenza Drugs and Vaccines Products Offered
12.10.5 Alvogen Recent Development
12.11 ABPI
12.11.1 ABPI Influenza Drugs and Vaccines Corporation Information
12.11.2 ABPI Influenza Drugs and Vaccines Business Overview and Total Revenue
12.11.3 ABPI Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.11.4 ABPI Influenza Drugs and Vaccines Products Offered
12.11.5 ABPI Recent Development
13 Influenza Drugs and Vaccines Manufacturing Cost Analysis
13.1 Influenza Drugs and Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Influenza Drugs and Vaccines
13.4 Influenza Drugs and Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Influenza Drugs and Vaccines Distributors List
14.3 Influenza Drugs and Vaccines Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Influenza Drugs and Vaccines Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Influenza Drugs and Vaccines Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market Influenza Drugs and Vaccines Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Influenza Drugs and Vaccines Sales (K MT) by Region (2015-2020)
Table 5. Global Influenza Drugs and Vaccines Sales Market Share by Region (2015-2020)
Table 6. Global Influenza Drugs and Vaccines Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Influenza Drugs and Vaccines Revenue Share by Region (2015-2020)
Table 8. Global Influenza Drugs and Vaccines Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Influenza Drugs and Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Influenza Drugs and Vaccines Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Influenza Drugs and Vaccines Revenue Share Forecast by Region (2021-2026)
Table 12. Global Influenza Drugs and Vaccines (K MT) of Key Companies (2015-2020)
Table 13. Global Influenza Drugs and Vaccines Sales Share by Company (2015-2020)
Table 14. Global Influenza Drugs and Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Influenza Drugs and Vaccines Revenue Share by Company (2015-2020)
Table 16. Global Influenza Drugs and Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Drugs and Vaccines as of 2019)
Table 17. Global Influenza Drugs and Vaccines Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Influenza Drugs and Vaccines Manufacturing Sites and Area Served
Table 19. Manufacturers Influenza Drugs and Vaccines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Influenza Drugs and Vaccines Players
Table 22. Global Influenza Drugs and Vaccines Sales (K MT) by Type (2015-2020)
Table 23. Global Influenza Drugs and Vaccines Sales Share by Type (2015-2020)
Table 24. Global Influenza Drugs and Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Influenza Drugs and Vaccines Price (K MT) by Type (2015-2020)
Table 26. Global Influenza Drugs and Vaccines Sales Share by Type (2021-2026)
Table 27. Global Influenza Drugs and Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Influenza Drugs and Vaccines Revenue Share by Type (2021-2026)
Table 29. Global Influenza Drugs and Vaccines Price (K MT) by Type (2021-2026)
Table 30. Global Influenza Drugs and Vaccines Sales (K MT) by Application (2015-2020)
Table 31. Global Influenza Drugs and Vaccines Sales Share by Application (2015-2020)
Table 32. Global Influenza Drugs and Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Influenza Drugs and Vaccines Price (K MT) by Application (2015-2020)
Table 34. Global Influenza Drugs and Vaccines Sales (K MT) by Application (2021-2026)
Table 35. Global Influenza Drugs and Vaccines Sales Share by Application (2021-2026)
Table 36. Global Influenza Drugs and Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Influenza Drugs and Vaccines Revenue Share by Application (2021-2026)
Table 38. Global Influenza Drugs and Vaccines Price (K MT) by Application (2021-2026)
Table 39. United States Influenza Drugs and Vaccines Sales (K MT) by Company (2015-2020)
Table 40. United States Influenza Drugs and Vaccines Sales Market Share by Company (2015-2020)
Table 41. United States Influenza Drugs and Vaccines Sales (K MT) by Type (2015-2020)
Table 42. United States Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
Table 43. United States Influenza Drugs and Vaccines Sales (K MT) by Application (2015-2020)
Table 44. United States Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
Table 45. Europe Influenza Drugs and Vaccines Sales (K MT) by Company (2015-2020)
Table 46. Europe Influenza Drugs and Vaccines Sales Market Share by Company (2015-2020)
Table 47. Europe Influenza Drugs and Vaccines Sales (K MT) by Type (2015-2020)
Table 48. Europe Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
Table 49. Europe Influenza Drugs and Vaccines Sales (K MT) by Application (2015-2020)
Table 50. Europe Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
Table 51. China Influenza Drugs and Vaccines Sales (K MT) by Company (2015-2020)
Table 52. China Influenza Drugs and Vaccines Sales Market Share by Company (2015-2020)
Table 53. China Influenza Drugs and Vaccines Sales (K MT) by Type (2015-2020)
Table 54. China Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
Table 55. China Influenza Drugs and Vaccines Sales (K MT) by Application (2015-2020)
Table 56. China Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
Table 57. Japan Influenza Drugs and Vaccines Sales (K MT) by Company (2015-2020)
Table 58. Japan Influenza Drugs and Vaccines Sales Market Share by Company (2015-2020)
Table 59. Japan Influenza Drugs and Vaccines Sales (K MT) by Type (2015-2020)
Table 60. Japan Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
Table 61. Japan Influenza Drugs and Vaccines Sales (K MT) by Application (2015-2020)
Table 62. Japan Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Influenza Drugs and Vaccines Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Influenza Drugs and Vaccines Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Influenza Drugs and Vaccines Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Influenza Drugs and Vaccines Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
Table 69. India Influenza Drugs and Vaccines Sales (K MT) by Company (2015-2020)
Table 70. India Influenza Drugs and Vaccines Sales Market Share by Company (2015-2020)
Table 71. India Influenza Drugs and Vaccines Sales (K MT) by Type (2015-2020)
Table 72. India Influenza Drugs and Vaccines Sales Market Share by Type (2015-2020)
Table 73. India Influenza Drugs and Vaccines Sales (K MT) by Application (2015-2020)
Table 74. India Influenza Drugs and Vaccines Sales Market Share by Application (2015-2020)
Table 75. GlaxoSmithKline Corporation Information
Table 76. GlaxoSmithKline Description and Business Overview
Table 77. GlaxoSmithKline Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. GlaxoSmithKline Influenza Drugs and Vaccines Product
Table 79. GlaxoSmithKline Recent Development
Table 80. Sanofi Pasteur Corporation Information
Table 81. Sanofi Pasteur Description and Business Overview
Table 82. Sanofi Pasteur Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Sanofi Pasteur Influenza Drugs and Vaccines Product
Table 84. Sanofi Pasteur Recent Development
Table 85. CSL Limited Corporation Information
Table 86. CSL Limited Description and Business Overview
Table 87. CSL Limited Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. CSL Limited Influenza Drugs and Vaccines Product
Table 89. CSL Limited Recent Development
Table 90. Astrazeneca Corporation Information
Table 91. Astrazeneca Description and Business Overview
Table 92. Astrazeneca Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Astrazeneca Influenza Drugs and Vaccines Product
Table 94. Astrazeneca Recent Development
Table 95. Protein Sciences Corporation Corporation Information
Table 96. Protein Sciences Corporation Description and Business Overview
Table 97. Protein Sciences Corporation Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Protein Sciences Corporation Influenza Drugs and Vaccines Product
Table 99. Protein Sciences Corporation Recent Development
Table 100. Serum Institute Of India Pvt. Ltd. Corporation Information
Table 101. Serum Institute Of India Pvt. Ltd. Description and Business Overview
Table 102. Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Product
Table 104. Serum Institute Of India Pvt. Ltd. Recent Development
Table 105. Emergent Biosolutions Corporation Information
Table 106. Emergent Biosolutions Description and Business Overview
Table 107. Emergent Biosolutions Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Emergent Biosolutions Influenza Drugs and Vaccines Product
Table 109. Emergent Biosolutions Recent Development
Table 110. Emergent Biosolutions Corporation Information
Table 111. Emergent Biosolutions Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Emergent Biosolutions Description and Business Overview
Table 113. Emergent Biosolutions Influenza Drugs and Vaccines Product
Table 114. Emergent Biosolutions Recent Development
Table 115. BioCryst Pharmaceuticals.Inc. Corporation Information
Table 116. BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. BioCryst Pharmaceuticals.Inc. Description and Business Overview
Table 118. BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Product
Table 119. BioCryst Pharmaceuticals.Inc. Recent Development
Table 120. Alvogen Corporation Information
Table 121. Alvogen Description and Business Overview
Table 122. Alvogen Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Alvogen Influenza Drugs and Vaccines Product
Table 124. Alvogen Recent Development
Table 125. ABPI Corporation Information
Table 126. ABPI Description and Business Overview
Table 127. ABPI Influenza Drugs and Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. ABPI Influenza Drugs and Vaccines Product
Table 129. ABPI Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Influenza Drugs and Vaccines Distributors List
Table 133. Influenza Drugs and Vaccines Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Drugs and Vaccines Product Picture
Figure 2. Global Influenza Drugs and Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Influenza Drugs and Vaccines Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Research Laboratories Examples
Figure 8. Pharmacies Examples
Figure 9. Others Examples
Figure 10. Global Influenza Drugs and Vaccines Sales (K MT) Growth Rate (2015-2026)
Figure 11. Global Influenza Drugs and Vaccines Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Influenza Drugs and Vaccines Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Influenza Drugs and Vaccines Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Influenza Drugs and Vaccines Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Influenza Drugs and Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Influenza Drugs and Vaccines Sales (K MT) Growth Rate (2015-2026)
Figure 17. Europe Influenza Drugs and Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Influenza Drugs and Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Influenza Drugs and Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Influenza Drugs and Vaccines Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Influenza Drugs and Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Influenza Drugs and Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Influenza Drugs and Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Influenza Drugs and Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Influenza Drugs and Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Influenza Drugs and Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Influenza Drugs and Vaccines Players Market Share by Revenue in Influenza Drugs and Vaccines 2015 & 2019
Figure 28. Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Influenza Drugs and Vaccines Revenue Share by Type (2015-2020)
Figure 30. Global Influenza Drugs and Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Influenza Drugs and Vaccines Revenue Share by Application (2015-2020)
Figure 32. Global Influenza Drugs and Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Influenza Drugs and Vaccines Sales Market Share by Type in 2019
Figure 34. United States Influenza Drugs and Vaccines Sales Market Share by Type in 2019
Figure 35. Europe Influenza Drugs and Vaccines Sales Market Share by Company in 2019
Figure 36. Europe Influenza Drugs and Vaccines Sales Market Share by Type in 2019
Figure 37. Europe Influenza Drugs and Vaccines Sales Market Share by Application in 2019
Figure 38. China Influenza Drugs and Vaccines Sales Market Share by Company in 2019
Figure 39. China Influenza Drugs and Vaccines Sales Market Share by Type in 2019
Figure 40. China Influenza Drugs and Vaccines Sales Market Share by Application in 2019
Figure 41. Japan Influenza Drugs and Vaccines Sales Market Share by Company in 2019
Figure 42. Japan Influenza Drugs and Vaccines Sales Market Share by Type in 2019
Figure 43. Japan Influenza Drugs and Vaccines Sales Market Share by Application in 2019
Figure 44. Southeast Asia Influenza Drugs and Vaccines Sales Market Share by Company in 2019
Figure 45. Southeast Asia Influenza Drugs and Vaccines Sales Market Share by Type in 2019
Figure 46. Southeast Asia Influenza Drugs and Vaccines Sales Market Share by Application in 2019
Figure 47. India Influenza Drugs and Vaccines Sales Market Share by Company in 2019
Figure 48. India Influenza Drugs and Vaccines Sales Market Share by Type in 2019
Figure 49. India Influenza Drugs and Vaccines Sales Market Share by Application in 2019
Figure 50. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. CSL Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Astrazeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Protein Sciences Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Serum Institute Of India Pvt. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Emergent Biosolutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Emergent Biosolutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. BioCryst Pharmaceuticals.Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Alvogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. ABPI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Key Raw Materials Price Trend
Figure 62. Manufacturing Cost Structure of Influenza Drugs and Vaccines
Figure 63. Manufacturing Process Analysis of Influenza Drugs and Vaccines
Figure 64. Influenza Drugs and Vaccines Industrial Chain Analysis
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Porter's Five Forces Analysis
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
鳥インフルエンザワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Avian Influenza Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides ac…- インフルエンザワクチンの世界市場レポート2020 Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 6…
- イヌインフルエンザワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Canine Influenza Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Canine Influenza Vac…
- 馬インフルエンザワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Equine Influenza Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Equine Influenza Vac…
- HPV治療ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global HPV Therapeutic Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The HPV Therapeutic Vacc…